Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Design features

V. Buckalew; A. Carr; J. Raines; H. Schnaper; N. Borhani; R. Grimm; W. Applegate; J. Sowers; R. Byington; G. Bond; H. Miller; S. Baumgardner; S. Brugger; C. Furberg; J. Cohn; C. D. Furberg; R. P. Byington

Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Design features

V. Buckalew, A. Carr, J. Raines, H. Schnaper, N. Borhani, R. Grimm, W. Applegate, J. Sowers, R. Byington, G. Bond, H. Miller, S. Baumgardner, S. Brugger, C. Furberg, J. Cohn, C. D. Furberg, R. P. Byington

Medicine - Cardiology Division

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Abstract

The Multicenter Isradipine Diuretic Atherosclerosis Study is a randomized, double-blind, clinical trial designed to compare the effectiveness of isradipine against hydrochlorothiazide in retarding the rate of progression of atherosclerotic lesions in the carotid arteries of hypertensive subjects. Eight hundred hypertensive men and women, 40 years of age or older, with minor plaques, are being recruited at eight clinical centers in the United States and will be followed for three years. Quantification of the atherosclerotic lesions at baseline and semiannually is done using B-mode ultrasonography. The background of the trial and its design features are discussed.

Original language	English (US)
Pages (from-to)	37-39
Number of pages	3
Journal	American Journal of Medicine
Volume	86
Issue number	4 A
State	Published - 1989

OpenUrl availability

Full text

Cite this

@article{ac832e87df4c4268b1cbc0fd2629256f,

title = "Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Design features",

abstract = "The Multicenter Isradipine Diuretic Atherosclerosis Study is a randomized, double-blind, clinical trial designed to compare the effectiveness of isradipine against hydrochlorothiazide in retarding the rate of progression of atherosclerotic lesions in the carotid arteries of hypertensive subjects. Eight hundred hypertensive men and women, 40 years of age or older, with minor plaques, are being recruited at eight clinical centers in the United States and will be followed for three years. Quantification of the atherosclerotic lesions at baseline and semiannually is done using B-mode ultrasonography. The background of the trial and its design features are discussed.",

author = "V. Buckalew and A. Carr and J. Raines and H. Schnaper and N. Borhani and R. Grimm and W. Applegate and J. Sowers and R. Byington and G. Bond and H. Miller and S. Baumgardner and S. Brugger and C. Furberg and J. Cohn and Furberg, {C. D.} and Byington, {R. P.}",

year = "1989",

language = "English (US)",

volume = "86",

pages = "37--39",

journal = "American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "4 A",

}

TY - JOUR

T1 - Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Design features

AU - Buckalew, V.

AU - Carr, A.

AU - Raines, J.

AU - Schnaper, H.

AU - Borhani, N.

AU - Grimm, R.

AU - Applegate, W.

AU - Sowers, J.

AU - Byington, R.

AU - Bond, G.

AU - Miller, H.

AU - Baumgardner, S.

AU - Brugger, S.

AU - Furberg, C.

AU - Cohn, J.

AU - Furberg, C. D.

AU - Byington, R. P.

PY - 1989

Y1 - 1989

N2 - The Multicenter Isradipine Diuretic Atherosclerosis Study is a randomized, double-blind, clinical trial designed to compare the effectiveness of isradipine against hydrochlorothiazide in retarding the rate of progression of atherosclerotic lesions in the carotid arteries of hypertensive subjects. Eight hundred hypertensive men and women, 40 years of age or older, with minor plaques, are being recruited at eight clinical centers in the United States and will be followed for three years. Quantification of the atherosclerotic lesions at baseline and semiannually is done using B-mode ultrasonography. The background of the trial and its design features are discussed.

AB - The Multicenter Isradipine Diuretic Atherosclerosis Study is a randomized, double-blind, clinical trial designed to compare the effectiveness of isradipine against hydrochlorothiazide in retarding the rate of progression of atherosclerotic lesions in the carotid arteries of hypertensive subjects. Eight hundred hypertensive men and women, 40 years of age or older, with minor plaques, are being recruited at eight clinical centers in the United States and will be followed for three years. Quantification of the atherosclerotic lesions at baseline and semiannually is done using B-mode ultrasonography. The background of the trial and its design features are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0024556531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024556531&partnerID=8YFLogxK

M3 - Article

C2 - 2523653

AN - SCOPUS:0024556531

SN - 0002-9343

VL - 86

SP - 37

EP - 39

JO - American Journal of Medicine

JF - American Journal of Medicine

IS - 4 A

ER -

Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Design features

Abstract

OpenUrl availability

Other files and links

Fingerprint

Cite this